A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity

被引：1

作者：

Patki, P ^{[1
]}

机构：

[1] Maharashtra Med Fdn, Dept Urol, Pune, Maharashtra, India

[2] St Peters Hosp, Chertsey, England

来源：

BJU INTERNATIONAL | 2006年 / 97卷 / 02期

关键词：

D O I：

10.1111/j.1464-410X.2006.06081_3.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：414 / 414

页数：1

共 50 条

[41] Urodynamic Changes Following Fewer Injection Sites of Intravesical Botulinum Toxin in Idiopathic Detrusor Overactivity: A Double-Blinded Prospective Randomized Clinical Trial
Soleimanifard, Niloofar
Nayeri, Reza Kaffash
Moghimian, Mehran
Tayebi, Sona
Emami, Maryam
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2025, : 567 - 574
[42] Efficacy and Tolerability of Botulinum Toxin Type A in Patients with Neurogenic Detrusor Overactivity and Without Concomitant Anticholinergic Therapy: Comparison of Two Doses
Grise, Philippe
Ruffion, Alain
Denys, Pierre
Egon, Guy
Kastler, Emmanuel Chartier
EUROPEAN UROLOGY, 2010, 58 (05) : 759 - 766
[43] DOES PRIOR TREATMENT WITH INTRAVESICAL BOTULINUM TOXIN A AFFECT THE OUTCOME OF SACRAL NEUROMODULATION EVALUATION IN PATIENTS WITH REFRACTORY DETRUSOR OVERACTIVITY?
Morton, H.
Harding, C.
NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S236 - S237
[44] PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING TRIGONAL VERSUS TRIGONE-SPARING INTRADETRUSOR INJECTION OF BOTULINUM TOXIN A FOR REFRACTORY IDIOPATHIC DETRUSOR OVERACTIVITY
Manecksha, R. P.
Cullen, I. M.
Ahmad, S.
Mcneill, G. J.
Mcdermott, T. E. D.
Flynn, R. J.
Grainger, R.
Thornhill, J. A.
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 191 - 191
[45] Efficacy of botulinum toxin A in the treatment of female idiopathic detrusor overactivity incontinence: Long-term results of a prospective nonrandomised study
Werner, Matthias
Kuschel, J. Stefanie
Schmid, Daniel M.
Schuessler, Bernhard
EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (11) : 685 - 690
[46] Botulinum toxin A injection in the detrusor muscle to treat overactive bladder syndrome and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy
Giannantoni, A.
Rossi, A.
Mearini, E.
Del Zingaro, M.
Porena, M.
Berardelli, A.
MOVEMENT DISORDERS, 2009, 24 : S320 - S320
[47] Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: Urodynamic outcome and patient satisfaction
Ghalayini, Ibrahim Fathi
Al-Ghazo, Mohammed A.
NEUROUROLOGY AND URODYNAMICS, 2007, 26 (04) : 531 - 536
[48] INJECTION OF BOTULINUM TOXIN TYPE A AS A THERAPEUTIC OPTION FOR BLADDER PRESERVATION IN PATIENTS WITH SEVERE NEUROGENIC DETRUSOR OVERACTIVITY
Williams, Taisha
Beck, M. E.
Lehrfeld, T. J.
Serio, J.
Nguyen, T.
Gordon, D. A.
NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 252 - 252
[49] Efficacy and safety of botulinum toxin-a in refractory idiopathic detrusor overactivity: Results from a randomised double blind placebo controlled trial.
Sahai, A.
Khan, M. S.
Dasgupta, P.
JOURNAL OF ENDOUROLOGY, 2006, 20 : A59 - A59
[50] INTRADETRUSOR INJECTION OF BOTULINUM NEUROTOXIN TYPE A IN PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY
Zugor, V.
Pothl, S.
Addalil, M.
Kuehn, R.
Labanaris, A. P.
ANTICANCER RESEARCH, 2014, 34 (11) : 6853 - 6853

← 1 2 3 4 5 →